Apparent treatment-resistant hypertension in ambulatory hypertensive patients in Northeast Ethiopia: prevalence, treatment patterns, and predictors
Why the study?
Data on apparent treatment-resistant hypertension in sub-Saharan Africa remain scarce, and the Northeast Amhara region of Ethiopia has been particularly underexplored.
Population
240 ambulatory adult hypertensive patients on at least one antihypertensive medication in Northeast Ethiopia
Design
Multi-center cross-sectional study
Key result
Apparent treatment-resistant hypertension was observed in 9.2% of patients, with at least one-time change in antihypertensive regimens being the sole predictor (AOR 2.85).
Authors
Loading...
Hypothesis-generating for regimen changes predicting aTRH; prospective studies needed before clinical adoption.
Cross-Sectional (n=240)
Yes
Apparent treatment-resistant hypertension is prevalent (9.2%) among ambulatory hypertensive patients in Northeast Ethiopia, with regimen changes being a significant predictor.
Effect estimate: AOR 2.85 (95% CI 1.14-7.10)
p-value: p=0.025
Hassen et al. (2026) conducted a cross-sectional in Hypertension (n=240). Antihypertensive regimen change vs. No regimen change was evaluated on Apparent treatment-resistant hypertension (aTRH) (AOR 2.85, 95% CI 1.14-7.10, p=0.025). Apparent treatment-resistant hypertension was observed in 9.2% of patients, with at least one-time change in antihypertensive regimens being the sole predictor (AOR 2.85).